Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 33, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness